FDA approves emergency use of single-dose vaccine from Johnson & Johnson

The Food and Drug Administration (FDA) on Saturday authorized the emergency use in the United States of the COVID-19 vaccine developed by Johnson & Johnson.

This is the third vaccine against COVID-19 to have received emergency use authorization from the FDA, after the first developed by the American pharmaceutical company Pfizer in partnership with its German colleague BioNTech, and the second developed by the American company Moderna.

It is also the first vaccine against COVID-19 requiring only a single injection available in the United States.

This clearance allows Johnson & Johnson’s vaccine to be distributed in the United States for use in people 18 years of age and older, according to the FDA.

All of the available data clearly demonstrates that the vaccine can be effective in preventing COVID-19, the FDA said in a statement.

They also show that the vaccine’s benefits outweigh its known and potential risks, which supports society’s demand for its use in people aged 18 and older, she added.

“The authorization of this vaccine expands the availability of vaccines, (which are) the best method of medical prevention against COVID-19, to help us in the fight against this pandemic which has claimed more than half a million lives in the United States, “said Janet Woodcock, acting commissioner of the FDA.

This approval came the day after a key FDA advisory committee recommended that the vaccine be approved for emergency use.

Unlike the vaccines from Pfizer-BioNTech and Moderna, the one from Johnson & Johnson only requires a single injection. In addition, it does not need to be stored at ultra-cold temperatures.

The United States remains the country worst affected by the pandemic, with more than 28 million cases and more than half a million deaths, according to the Center for Systems Science and Engineering at Johns Hopkins University.

US President Joe Biden’s national vaccination campaign aims to deliver 100 million two-phase doses against the novel coronavirus in the first 100 days of his tenure.

More than 96 million doses have been distributed across the United States as of Saturday, and more than 72 million have been administered, according to data from the U.S. Centers for Disease Control and Prevention.

News Room
News Roomhttps://www.megalopreneur.com
Stories under this byline are written/directed/published by the staff and editorial board of MegaloPreneur magazine. Some of the MegaloPreneur journalists may also be involved in investigating and finding facts.

Your Comment

Discover

Sponsor

spot_imgspot_img

Latest

The first Ukrainian ship with grain from Istanbul left for Lebanon

A ship under the flag of Sierra Leone, loaded with more than 26,500 tons of corn, arrived on Tuesday evening in the Strait of...

Von der Leyen – We have to prepare for the worst possible scenario with gas

We must remain united because they are the only ones responsible for this energy crisis in Moscow and nowhere else, she stated The President of...

Kalin on the export of grain from Ukraine – The ships are loaded and ready to go

There is a high probability that the first ship will be able to leave tomorrow morning if everything is regulated by tonight, said Kalin The...

Inflation in the eurozone at a record 8.9 percent

The Baltic countries recorded the highest annual inflation rates in July, and Estonia again had the highest, at 22.7 percent. Inflation in the Eurozone accelerated...

Lavrov spoke to Blinken – The war will end faster if you stop sending weapons

I pressed the Kremlin to accept the proposal we made to release Paul Whelan and Brittney Griner, Blinken said US Secretary of State Anthony Blinken...